Do IRBs Pass the Minimal Harm Test?

Area of Science:

• Biomedical Research Ethics
• Regulatory Science
• Human Subjects Protection

Background:

• Institutional Review Boards (IRBs) are essential for protecting human research participants.
• However, some IRB actions can impede research, particularly studies involving minimal risk.
• This can lead to unnecessary delays and increased costs in scientific advancement.

Purpose of the Study:

• To highlight instances where IRB oversight has hindered low-risk research.
• To propose specific improvements to the IRB review process.
• To reduce the human and financial burden associated with IRB procedures.

Main Methods:

• Analysis of case examples where IRB actions negatively impacted minimal-risk research.
• Review of current IRB processes and their potential inefficiencies.
• Development of actionable recommendations for process enhancement.

Main Results:

• Identified specific IRB actions that unnecessarily delayed or stopped minimal-risk studies.
• Documented the human and financial costs associated with these delays.
• Formulated three concrete proposals for optimizing the IRB review pathway.

Conclusions:

• IRB processes can be improved to better balance participant protection with research efficiency.
• Implementing proposed changes can streamline reviews for minimal-risk research.
• Optimized IRB procedures will reduce costs and accelerate the pace of important scientific discovery.